Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Sell
31
STIM Quote, Financials, Valuation and Earnings
Last price:
$4.26
Seasonality move
:
2.88%
Day range:
$4.14 - $4.34
52-week range:
$0.52 - $5.92
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.91x
P/B ratio:
7.96x
Volume:
420.8K
Avg. volume:
871.4K
1-year change:
64.37%
Market cap:
$282.4M
Revenue:
$74.9M
EPS (TTM):
-$1.31
Earnings Data
Next earnings date for STIM
Aug 12
2025
Most recent earnings per share
-$0.21
Missed by $0.09
(May 6/2025)
Consensus Estimate
-$0.12
(May 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
STIM Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/12/2025 | Q2 | $36.6M | -- | -- | -$0.08 | -- |
| 05/06/2025 | Q1 | $29.1M | $32M | -$0.21 | -$0.12 | -$0.09 |
| 03/04/2025 | Q4 | $19M | $22.5M | -$0.33 | -$0.24 | -$0.09 |
| 11/12/2024 | Q3 | $19.1M | $18.5M | -$0.44 | -$0.23 | -$0.21 |
| 08/12/2024 | Q2 | $18.7M | $16.5M | -$0.33 | -$0.27 | -$0.06 |
| 05/07/2024 | Q1 | $17.1M | $17.4M | -$0.27 | -$0.31 | $0.04 |
| 03/05/2024 | Q4 | $20M | $20.3M | -$0.19 | -$0.26 | $0.07 |
| 11/07/2023 | Q3 | -- | -- | -$0.33 | -$0.29 | -$0.05 |
| 08/08/2023 | Q2 | -- | -- | -$0.17 | -$0.35 | $0.18 |
| 05/09/2023 | Q1 | -- | -- | -$0.38 | -$0.39 | $0.01 |
| 03/07/2023 | Q4 | -- | -- | -$0.30 | -$0.38 | $0.08 |
| 11/08/2022 | Q3 | -- | -- | -$0.28 | -$0.43 | $0.15 |
| 08/02/2022 | Q2 | -- | -- | -$0.39 | -$0.41 | $0.02 |
| 05/12/2022 | Q1 | -- | -- | -$0.41 | -$0.40 | -$0.01 |
| 03/08/2022 | Q4 | -- | -- | -$0.29 | -$0.32 | $0.03 |
| 11/09/2021 | Q3 | -- | -- | -$0.31 | -$0.30 | -$0.01 |
| 08/03/2021 | Q2 | -- | -- | -$0.29 | -$0.24 | -$0.05 |
| 05/04/2021 | Q1 | -- | -- | -$0.31 | -$0.31 | -$0.00 |
| 03/02/2021 | Q4 | -- | -- | -$0.19 | -$0.26 | $0.07 |
| 11/02/2020 | Q3 | -- | -- | -$0.18 | -$0.28 | $0.10 |
| 08/04/2020 | Q2 | -- | -- | -$0.41 | -$0.50 | $0.09 |
| 05/05/2020 | Q1 | -- | -- | -$0.68 | -$0.46 | -$0.22 |
| 03/03/2020 | Q4 | -- | -- | -$0.41 | -$0.45 | $0.04 |
| 11/05/2019 | Q3 | -- | -- | -$0.37 | -$0.43 | $0.06 |
| 08/06/2019 | Q2 | -- | -- | -$0.39 | -$0.41 | $0.02 |
| 05/07/2019 | Q1 | -- | -- | -$0.42 | -$0.40 | -$0.02 |
| 03/05/2019 | Q4 | -- | -- | -$0.35 | -$0.36 | $0.01 |
| 11/06/2018 | Q3 | -- | -- | -$0.29 | -$0.40 | $0.11 |
| 08/14/2018 | Q2 | -- | -- | -$0.67 | -$0.88 | $0.21 |
Neuronetics Earnings Questions
-
How Much did Neuronetics Generate in Revenue Last Quarter?
Neuronetics reported $32M worth of top line sales in its most recent quarter.
-
Did Neuronetics Beat Earnings Last Quarter?
Neuronetics announced earnings per share of -$0.21 which represents a miss of analyst forecast a -$0.12 per share.
-
Is Neuronetics Profitable?
Neuronetics reported $15.7M that represents $0.26 per share over the last quarter.
-
What is the Analyst Consensus for Neuronetics EPS Next Year?
Neuronetics's earnings are forecast to decrease from -$1.38 per share to -$1.27 per share next year representing a decrease of -74.28%.
-
When is Neuronetics's Earnings Date?
Neuronetics's next earnings date is August 12, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Mobileye Might Be Wall Street’s Next Big Surprise
The trend to automate vehicles started long ago when adding…
Why Is Rigetti Stock Going Up?
Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
99
SOC alert for May 20
Sable Offshore [SOC] is down 0.79% over the past day.
Buy
52
RGC alert for May 20
Regencell Bioscience Holdings [RGC] is up 31.16% over the past day.
Sell
40
GWLIF alert for May 20
Great-West Lifeco [GWLIF] is up 13.42% over the past day.
